Nora Kochupurakkal, PhD
About Nora Kochupurakkal, PhD
Nora Kochupurakkal, PhD, is a Senior Analytical Scientist at Evelo Biosciences in Cambridge, Massachusetts, where she has worked since 2020. She has extensive experience in the field, having previously held positions at Amgen, Dana Farber Cancer Institute, and Boston Children's Hospital.
Work at Evelo Biosciences
Nora Kochupurakkal has been employed at Evelo Biosciences since 2020, serving as a Senior Analytical Scientist. In this role, she contributes to the development and analysis of innovative therapies aimed at treating diseases through the modulation of the microbiome. Her work is based in Cambridge, Massachusetts, where she has been part of the team for four years.
Previous Experience at Amgen
Prior to her current position, Nora Kochupurakkal worked at Amgen from 2015 to 2020 as a Scientist. During her five years at Amgen, she focused on advancing biopharmaceuticals and contributed to various projects within the organization, enhancing her expertise in analytical sciences.
Academic Background and Education
Nora Kochupurakkal holds a Doctor of Philosophy (PhD) in Immunology from the University of Basel, where she studied from 1999 to 2002. She also completed a Diploma in Human Biology at Universität Greifswald from 1999 to 2002. Additionally, she studied Biology at The University of Göttingen and FAU Erlangen-Nürnberg, achieving Vordiplom qualifications. Her educational background has provided her with a strong foundation in biological sciences.
Research Experience at Dana Farber Cancer Institute
Nora Kochupurakkal served as a Postdoctoral Fellow at Dana Farber Cancer Institute from 2007 to 2009. In this role, she engaged in cancer research, contributing to the understanding of cancer biology and treatment approaches. This position followed her research fellowship at Boston Children's Hospital, where she worked from 2009 to 2015.
Visiting Scientist Role at Weizmann Institute of Science
Nora Kochupurakkal was a Visiting Scientist at the Weizmann Institute of Science from 2002 to 2004. This experience allowed her to collaborate with leading researchers and gain insights into advanced scientific methodologies, further enriching her research capabilities.